Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimada

Showing results (311-320 of 360) with videos related to

Pageof 36
Sort By:
British Journal of Haematology|September 15, 2025
Differential transcript level of ANKRD26 and clinical phenotype among the ANKRD26 variants in the Japanese registry for congenital thrombocytopeniaAtsushi Sakamoto, Toru Uchiyama, Kazuhiko Nakabayashi, et al.
Diabetes|February 4, 2011
RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetesKaoru Aida, Yoriko Nishida, Shoichiro Tanaka, et al.
Diabetology International|January 4, 2019
Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitusMegu Yamaguchi Baden, Akihisa Imagawa, Hiromi Iwahashi, et al.
Pediatric Blood & Cancer|December 6, 2023
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factorTakahiro Aoki, Norio Shiba, Shinichi Tsujimoto, et al.
Diabetes|December 16, 2018
Genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in <i>CSAD/lnc-ITGB7-1</i> on Chromosome 12q13.13 Associated With Susceptibility to Fulminant Type 1 DiabetesYumiko Kawabata, Nao Nishida, Takuya Awata, et al.
International Journal of Hematology|May 23, 2016
JAK2, MPL, and CALR mutations in children with essential thrombocythemiaYuko Sekiya, Yusuke Okuno, Hideki Muramatsu, et al.
International Journal of Hematology|July 2, 2015
Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocolsDaisuke Tomizawa, Tomoyuki Watanabe, Ryoji Hanada, et al.
Pediatric Blood & Cancer|December 27, 2019
The effect of graft-versus-host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adultsTetsuo Mitsui, Naoto Fujita, Yuhki Koga, et al.
International Journal of Hematology|September 4, 2025
Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 studyHiroyuki Takahashi, Shiro Tanaka, Yuki Yuza, et al.
Leukemia|May 5, 2026
Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesisSatoshi Saida, Tsutomu Toki, Ritsuko Shimizu, et al.
Pageof 36

Showing results (311-320 of 360) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|September 15, 2025
Differential transcript level of ANKRD26 and clinical phenotype among the ANKRD26 variants in the Japanese registry for congenital thrombocytopeniaAtsushi Sakamoto, Toru Uchiyama, Kazuhiko Nakabayashi, et al.
Diabetes|February 4, 2011
RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetesKaoru Aida, Yoriko Nishida, Shoichiro Tanaka, et al.
Diabetology International|January 4, 2019
Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitusMegu Yamaguchi Baden, Akihisa Imagawa, Hiromi Iwahashi, et al.
Pediatric Blood & Cancer|December 6, 2023
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factorTakahiro Aoki, Norio Shiba, Shinichi Tsujimoto, et al.
Diabetes|December 16, 2018
Genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in <i>CSAD/lnc-ITGB7-1</i> on Chromosome 12q13.13 Associated With Susceptibility to Fulminant Type 1 DiabetesYumiko Kawabata, Nao Nishida, Takuya Awata, et al.
International Journal of Hematology|May 23, 2016
JAK2, MPL, and CALR mutations in children with essential thrombocythemiaYuko Sekiya, Yusuke Okuno, Hideki Muramatsu, et al.
International Journal of Hematology|July 2, 2015
Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocolsDaisuke Tomizawa, Tomoyuki Watanabe, Ryoji Hanada, et al.
Pediatric Blood & Cancer|December 27, 2019
The effect of graft-versus-host disease on outcomes after allogeneic stem cell transplantation for refractory lymphoblastic lymphoma in children and young adultsTetsuo Mitsui, Naoto Fujita, Yuhki Koga, et al.
International Journal of Hematology|September 4, 2025
Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 studyHiroyuki Takahashi, Shiro Tanaka, Yuki Yuza, et al.
Leukemia|May 5, 2026
Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesisSatoshi Saida, Tsutomu Toki, Ritsuko Shimizu, et al.
Pageof 36